Based on the above findings, we propose that PD-L1 enriched EVs derived from tumor cells expressing high levels of p-HRS may be distributed in the local tumor microenvironment, likely scaffolded on the ECM, to block the infiltration of CD8+ T cells (Supplementary Fig. 14). Here, CD8A is linked to neoplasm.